DAPH ≥98% (by HPLC)

Proveedor: Enzo Life Sciences

ALEXBML-EI386-0005EA 181 EUR
DAPH ≥98% (by HPLC)

DAPH abolishes or greatly reduces previously existing fully formed β-amyloid (1-42) fibrils and eliminates β-amyloid (1-42) peptide neurotoxicity. Also inhibits EGFR kinase. IC50 for inhibition of β-sheet content of aggregated β-amyloid (1-42) is 4.5µM.

  • EGFR inhibitor

Orange solid.

Soluble in DMSO (25mg/ml).

Formula: C₂₀H₁₅N₃O₂
MW: 329,4
Temperatura de almacenaje: Congelador
Núm. CAS: 145915-58-8

Order Now

Learn more

About VWR

Avantor is a vertically integrated, global supplier of discovery-to-delivery solutions for...

Más About VWR